GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vimta Labs VIMTALABS.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

504.50

+1.62%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Vimta Labs

Its shares trade on NSE under the ticker VIMTALABS.NS. It has been listed since 13 September 1993. In the fiscal year to 31 March 2026, it reported revenue of ₹4.07bn and net income of ₹775.1m. At that date it held total assets of ₹5.62bn and shareholders' equity of ₹4.57bn.

Vimta Labs Ltd. engages in the provision of contract research and testing. The company is headquartered in Hyderabad, Telangana. The firm is engaged in providing a range of services to biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, power, cement, oil and gas, ores and minerals, infrastructure and many other industries, government organizations as well as other industry participants. Its services include Drug discovery, development, and drug life cycle management support services; Preclinical research and testing services for medical device companies; Contract research and testing for agrochemical and specialty chemical companies; and Food testing and analytical development services to support manufacturers, processors, farmers, and retailers; Clinical diagnostics services to patients, clinicians, and hospitals, and environmental regulatory services such as impact assessments and post project monitoring, to various industries, such as power and infrastructure.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Life Sciences Tools & Services
Listed since
13 Sept 1993
Employees
1,368
Website
vimta.com ↗

Leadership

Pay as last reported

  • Dr. Sivalinga VasireddiExecutive Chairman of the Board, since 2023₹4.1m
  • Shri. Siva Rama KambhampatiChief Financial Officer
  • Mrs. Sujani VasireddiCompany Secretary, Compliance officer
  • Ms. Harita VasireddiManaging Director, Executive Director, since 2022₹16.4m
  • Mr. Satya NeerukondaExecutive Director, since 2019₹15.2m
  • Shri. Harriman VungalExecutive Director - Operations, since 2021₹15.9m
  • Mr. Sanjay DaveNon-Executive Independent Director₹200,000
  • Mr. Purnachandra GuttaNon-Executive Independent Director₹200,000
  • Mr. Yadagiri PendriNon-Executive Independent Director
  • Smt. Yalamanchili RaniNon-Executive Independent Director₹200,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Vimta Labs Ltd. provides comprehensive services to biopharmaceutical and medical device industries in Hyderabad.
  • Vimta Labs Ltd. serves diverse sectors including food, agrochemical, and environmental regulatory services.
  • Vimta Labs Ltd. employs 1,368 full-time employees supporting multiple industry segments.

Weaknesses

  • Vimta Labs Ltd. has limited presence in the Information Technology sector.
  • Vimta Labs Ltd. does not serve the Financials sector directly.
  • Vimta Labs Ltd. lacks services in the Consumer Discretionary industry.

Opportunities

  • Vimta Labs Ltd. can expand into the Materials sector for ore and mineral testing.
  • Vimta Labs Ltd. can leverage its food testing services for global markets.
  • Vimta Labs Ltd. can grow in the Real Estate sector for environmental assessments.

Threats

  • Vimta Labs Ltd. faces competition from other Health Care providers in Hyderabad.
  • Vimta Labs Ltd. must adapt to new environmental regulations in the power sector.
  • Vimta Labs Ltd. needs to address potential regulatory changes in the medical device industry.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.